Literature DB >> 1538586

Syndecan in carcinomas produced from transformed epithelial cells in nude mice.

P Inki1, H Kujari, M Jalkanen.   

Abstract

Expression of syndecan, a cell surface proteoglycan, was studied in carcinomas induced by implanting chemically transformed keratinocytes and mammary epithelial cells into nude mice. By immunohistochemistry and in situ hybridization, syndecan was localized in keratinizing cells within moderate- to well-differentiated squamous cell carcinomas in a pattern resembling that of normal epidermis, whereas almost total loss of expression was detected in poorly-differentiated areas within these tumors. In anaplastic spindle cell carcinomas, syndecan expression was barely detectable. In biphasic tumors, induced by mammary epithelial cells, and consisting of cysts overlaying an adenocarcinoma, syndecan was unquely localized to differentiated epithelial structures such as secretory epithelial lining of the cysts as well as aberrant glands and ducts within the carcinoma. Based on the expression pattern of syndecan in the tumors studied, we conclude that the expression of this developmentally regulated molecule is associated with epithelial differentiation also during neoplastic growth.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1538586

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  6 in total

1.  Translational suppression of syndecan-1 expression in Ha-ras transformed mouse mammary epithelial cells.

Authors:  J Kirjavainen; S Leppä; N E Hynes; M Jalkanen
Journal:  Mol Biol Cell       Date:  1993-08       Impact factor: 4.138

2.  Syndecan-1 alterations during the tumorigenic progression of human colonic Caco-2 cells induced by human Ha-ras or polyoma middle T oncogenes.

Authors:  P Levy; A Munier; S Baron-Delage; Y Di Gioia; C Gespach; J Capeau; G Cherqui
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

3.  Syndecan-1 expression has prognostic significance in head and neck carcinoma.

Authors:  A Anttonen; M Kajanti; P Heikkilä; M Jalkanen; H Joensuu
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

4.  Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.

Authors:  S Mikami; K Ohashi; Y Usui; T Nemoto; K Katsube; M Yanagishita; M Nakajima; K Nakamura; M Koike
Journal:  Jpn J Cancer Res       Date:  2001-10

5.  "Trans-differentiation" from epidermal to mesenchymal/myogenic phenotype is associated with a drastic change in cell-cell and cell-matrix adhesion molecules.

Authors:  P Boukamp; N E Fusenig
Journal:  J Cell Biol       Date:  1993-02       Impact factor: 10.539

6.  Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck.

Authors:  P Inki; H Joensuu; R Grénman; P Klemi; M Jalkanen
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.